![]() ![]() The risk of death is greatly increased following a positive test for COVID-19 even in young people, and many studies show that vaccines are highly effective at preventing hospitalisation or death following COVID-19 infection. While vaccination carries some risks, these need to be assessed in light of the benefits of vaccination. Those who received non-mRNA vaccines were more likely to be clinically vulnerable and may be at greater risk of adverse events following vaccination than the general population. There was no increased risk for young men for either vaccine type. However, there was an increased risk of cardiac death in young women after a first dose of non-mRNA vaccines, with the risk being 3.5 times higher in the 12 weeks following vaccination, compared with the longer-term risk. No increased risk of cardiac or all-cause death for young people in general in the weeks after vaccinationĪssessing the impact of COVID-19 vaccination and positive SARS-CoV-2 tests on the risk of cardiac and all-cause death in young people (aged 12 to 29 years) in England (8 December 2020 to ) showed that there was no significant increase in cardiac or all-cause death in the 12 weeks following COVID-19 vaccination compared with more than 12 weeks after any dose. People reporting fair health (77.8%) were the highest proportion of people continuing from a third to a fourth vaccination individuals in very good health (71.8%) had the lowest continuation from third to fourth dose, followed by those in very bad health (73.1%). Among individuals aged under 60 years, continuation to the fourth dose was lowest for those with no self-reported long-term health conditions. People who have long-term health issues or a disability but are not reduced at all had the highest continuation for all age groups, from age 40 years and over. Read more about this in our Coronavirus and vaccination rates in adults by socio-demographic characteristic and occupation, England: December 2020 to March 2023 bulletinĭownload this chart For age bands above 60 years, individuals who are reduced a lot in their day-to-day activities had lower continuation to their fourth vaccination Imageįor individuals aged 60 years and over, the continuation from third to fourth vaccination was lowest among those who report they are reduced a lot in their day-to-day activities by their long-term health condition or disability. Data may differ from weekly administrative vaccination data published by NHS England. Vaccination data are produced using linked data from Deaths registrations and Census 2021, National Immunisation Management Service, Hospital Episode Statistics, and General Practise Extraction Service data for Pandemic Planning and Research. ![]() Younger age groups had lower continuation, with less than half of eligible individuals aged 18 to 29 years (38.6%) and 30 to 39 years (44.1%) receiving their fourth dose. The continuation from third to fourth dose of the COVID-19 vaccine was highest among individuals aged 80 years and over (94.0%) and those aged between 70 and 79 years (91.9%). ![]() Of those who had received three doses and were eligible, 77.7% had continued to their fourth vaccination. Download this chart The number of eligible individuals with three vaccinations who continue to their fourth vaccination is higher in older age groups ImageĪmong people aged 18 years and over, 75.8% had received at least three COVID-19 vaccinations as of 2 March 2023. ![]()
0 Comments
Leave a Reply. |